U.S. Oil and Gas Stock News

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see JAKKS...

It's been a pretty great week for Ralph Lauren Corporation ( NYSE:RL ) shareholders, with its shares surging 16% to...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Recent share performance and business snapshot With no single headline event driving attention to U-Haul Holding (UHAL), investors are focusing on the stock’s mixed recent returns and the scale of its core moving and storage operations. The stock is up 0.7% over the past day and 5.9% over the past week, while it is down 2.0% over the past month and up 2.3% over the past 3 months. Year to date, the total return is 2.0%, but the total return over the past year is down 16.8% and the total return...

Maase (MAAS) has drawn fresh attention after a sharp recent move in its stock, prompting investors to look more closely at this China focused financial services and technology platform listed on the Nasdaq. See our latest analysis for Maase. The recent surge in Maase’s share price, including a 9.22% 1 day share price return and 103.43% year to date share price return, points to strengthening momentum as investors reassess its China focused financial technology platform. If Maase’s move has...

ProFrac Holding (ACDC) has drawn fresh attention after recent share price moves, with the stock down around 3% over the past week yet up sharply over the past 3 months and year to date. See our latest analysis for ProFrac Holding. That recent pullback comes after a strong run, with a 90 day share price return of 39.92% and a year to date share price return of 76.98%, even as the 3 year total shareholder return remains down 38.99%. If this kind of move has you thinking about where else...

Mativ Holdings, Inc. ( NYSE:MATV ) stock is about to trade ex-dividend in four days. Typically, the ex-dividend date is...

Earlier this year, ON Semiconductor reported Q4 2025 non-GAAP EPS of US$0.64, generated record free cash flow, approved a US$6.00 billion buyback, and introduced vertical GaN power semiconductors targeting AI data centers and electric vehicles. The combination of strong cash generation, a very large repurchase plan, and new GaN products aimed at high-growth power markets has sharpened investor focus on how ON Semiconductor balances capital returns with long-term technology investment. We’ll...

At its recent J.P. Morgan Auto Group Investor Meeting, Adient raised its fiscal 2026 guidance after strong first-half execution, highlighting approximately US$1.10 billion in new annual business wins in China, 18% China sales growth in the first half of fiscal 2026, and continued market share gains in the Americas. Beyond higher guidance, the company emphasized how automation, AI-enabled smart manufacturing, and a new China joint venture are reshaping its operations and customer...

Wondering whether Xylem stock offers good value at today’s price, or if the recent moves are already pricing in its strengths. The share price closed at US$110.28, with a 7 day gain of 2.0%, but it is down 9.2% over the past 30 days and down 19.6% year to date. This may change how you think about both upside potential and risk. Over the past 1 year the stock is down 10.0%, while the 3 year return sits at 15.9% and the 5 year return is down 1.2%. This gives useful context for anyone looking...

Why MYR Group (MYRG) Is On Investors’ Radar Now MYR Group (MYRG) is back in focus after reporting robust earnings per share growth, stronger free cash flow margins, and recent share repurchases that collectively point to a more efficient use of capital. See our latest analysis for MYR Group. The recent earnings strength sits alongside a sharp move in the stock, with a 30-day share price return of 31.72% and a 90-day share price return of 62.82%. The 1-year total shareholder return of 183.91%...

Earlier in May 2026, Regeneron Pharmaceuticals reported that its Phase 3 trial of fianlimab plus cemiplimab in first-line metastatic melanoma did not reach statistical significance for progression-free survival versus pembrolizumab, prompting multiple law firm investigations into whether prior communications about the program misled investors. At the same time, Regeneron unveiled very strong early-phase data for Lynozyfic in relapsed systemic AL amyloidosis and advanced a new Helicon-based...

Earlier this week, Flowers Foods reported first-quarter 2026 results showing net sales of US$1,571.58 million, modestly higher year on year, but with net income and earnings per share lower than the prior period, alongside updated full-year guidance, a reduced quarterly dividend of US$0.1250, and continued share repurchases. At the same time, the company relaunched its flagship Nature’s Own brand with simpler, Non-GMO recipes and a major multi-platform “Breaducator” marketing push, signaling...

Recent performance snapshot APi Group (APG) has drawn fresh attention after a period in which the stock is up about 7% year to date, while showing declines over the past month and the past three months. See our latest analysis for APi Group. Short term, the stock has lost some momentum, with a 30 day share price return of down 14.34% and a 90 day share price return of down 5.62%. Its 1 year total shareholder return of 36.91% and 3 year total shareholder return of about 17x highlight how...

Earlier this month, Red Hat announced new milestones in its collaboration with F5, introducing F5 WAF for NGINX on NGINX Gateway Fabric and AI quickstarts for Red Hat OpenShift AI to enhance Kubernetes-native and AI-powered application security for enterprise customers. The move highlights how F5 is embedding security-as-code and validated AI chatbot architectures directly into cloud-native workflows, aiming to make advanced protection more accessible for organizations handling sensitive...

Union Pacific Corporation ( NYSE:UNP ) is about to trade ex-dividend in the next four days. The ex-dividend date occurs...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Readers hoping to buy T-Mobile US, Inc. ( NASDAQ:TMUS ) for its dividend will need to make their move shortly, as the...

Despite the fact that Chaince Digital Holdings Inc.'s (NASDAQ:CD) value has dropped 11% in the last week insiders who...

Ross Stores, Inc. ( NASDAQ:ROST ) just released its quarterly report and things are looking bullish. Ross Stores beat...

LuxExperience B.V (LUXE) drew fresh attention after reporting third quarter and nine month results that paired higher sales with a wider net loss, while also closing the sale of THE OUTNET and outlining a YNAP transformation plan. See our latest analysis for LuxExperience B.V. The latest quarter, with higher sales but a wider loss and fresh restructuring charges, has coincided with pressure on the stock, which is down 21.31% on a 1 month share price basis and 22.53% on a 1 year total...

In May 2026, Enhanced, an elite sports competition and consumer products company, announced a content and distribution partnership with Rumble to stream the inaugural Enhanced Games from Las Vegas and future events, while also leveraging Rumble’s Advertising Center to promote its Live Enhanced platform. This deal gives Rumble another live-sports style content vertical and a targeted advertising client that aims to improve customer acquisition efficiency using its platform. Next, we’ll...

Earlier in May 2026, VEON Ltd. reported first-quarter 2026 results showing revenue of US$1,201 million versus US$1,026 million a year earlier, with net income steady at US$99 million and basic and diluted earnings per share from continuing operations unchanged at US$1.5. Alongside raising its 2026 revenue growth guidance, launching a US$100 million share buyback, and issuing US$1.4 billion of new bonds to refinance existing debt, VEON highlighted rapidly expanding digital revenues and...

AbCellera Biologics (ABCL) is back on investors’ radar after early Phase 1 data for its lead program ABCL635 and a fresh quarterly earnings report that shows higher revenue and a smaller net loss. See our latest analysis for AbCellera Biologics. The recent Phase 1 data for ABCL635 and the quarterly update appear to have coincided with a sharp acceleration in momentum, with the stock showing a 27.14% 7 day share price return, a 71.62% 90 day share price return, and a 163.96% 1 year total...